Global Cancer Diagnostics Market The global cancer diagnostics market was estimated to be USD 16.55 billion in year 2016. It is expected to reach USD 232.7 billion by 2025 as per a new report released by Grand View Research, Inc. This boost in the cancer diagnostics market is majorly attributed to the advances in diagnostic…
DetailsCancer is the second most common cause of death after heart disease. The treatment of cancer depends upon the type of cancer and at what stage it is being diagnosed. Due to low socioeconomic status and low literacy rate, patients often opt traditional methods and alternative medicines instead of seeking proper treatment. There are numerous…
DetailsHealthcare systems are driven by regulations which ensure patient’s access to safe, effective, and high-quality products. Regulations are basically rules which are framed by the government or the regulatory authority of the respective region so that risk associated with public health is under scanner. Regulations help in improving the quality and affordability of healthcare. These…
DetailsEvidence-based practice (EBP) is defined asthe conscientious, explicit and judicious use of current best evidence in making correct, prompt and individualistic patient care decisions. (Sackett D, 1996) EBP integrates the clinician’sown expertise, the best available scientific evidence, and the patient values and preferences (Figure 1). Figure 1: Elements of Evidence-Based Practice (EBP) Inability of current…
DetailsMergers and acquisitions (M&As) refer to consolidation of companies or assets. Merger means combining two companies into one, while acquisition refers to taking over of one company by the other one. In pharmaceutical world, mergers and acquisitions are quite common. According to the insights, M&As help the pharmaceutical companies in achieving their goals easily by…
Details
